Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 939163 | ISIN: US83175M2052 | Ticker-Symbol: NPWA
Siehe auch SMITH & NEPHEW PLC
Frankfurt
27.06.25 | 08:00
25,800 Euro
+0,78 % +0,200
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SMITH & NEPHEW PLC ADR Chart 1 Jahr
5-Tage-Chart
SMITH & NEPHEW PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
25,80026,20028.06.

Aktuelle News zur SMITH & NEPHEW PLC ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SMITH & NEPHEW PLC ADR Aktie jetzt für 0€ handeln
13:10Smith & Nephew UK Ltd: Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair64Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world's...
► Artikel lesen
MiSmith+Nephew launches Trigen Max tibia nailing system5
DiSmith+Nephew appoints chief corporate development & strategy officer3
DiSmith & Nephew UK Ltd: Smith+Nephew's new TRIGEN MAX Tibia Nailing System brings 'next-level nailing' to trauma surgeons repairing tibial fractures250The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces...
► Artikel lesen
MoSmith & Nephew hires Mckinsey alum Ajay Dhankar to executive board3
MoSmith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer5
MoSmith & Nephew UK Ltd: Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer269Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will...
► Artikel lesen
20.06.Smith+Nephew Stock May Gain From Strategic Deal With Standard Health3
18.06.Smith+Nephew to open first orthopedic ambulatory surgery center in the UK3
18.06.Smith & Nephew UK Ltd: Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK466Smith+Nephewto support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading...
► Artikel lesen
13.06.Smith+Nephew opens new medtech center in Barcelona4
13.06.Smith+Nephew ernennt David King zum Non-Executive Director7
13.06.Smith+Nephew appoints David King as non-executive director2
13.06.Smith & Nephew Plc - Directorate Change7
10.06.Smith+Nephew introduces new medial stabilized insert for Legion TKS4
09.06.Smith & Nephew UK Ltd: New medial stabilized insert for Smith+Nephew's LEGION Total Knee System designed to improve kinematics, stability and procedural versatility322Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts...
► Artikel lesen
06.06.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer4
06.06.Smith & Nephew Plc - Director/PDMR Shareholding2
02.06.Smith & Nephew Plc - Total Voting Rights4
30.05.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer1
Weiter >>
116 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1